Are you Dr. Ferguson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
28815 8 Mile Rd
Suite 103
Livonia, MI 48152Phone+1 248-478-6806Fax+1 248-478-6908
Summary
- Dr. Gary Ferguson, MD is a pulmonologist in Livonia, Michigan. He is currently licensed to practice medicine in Michigan, Florida, and Colorado. He is affiliated with Corewell Health Farmington Hills Hospital and Ascension Providence Hospital, Southfield Campus.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
University of WashingtonResidency, Internal Medicine, 1980 - 1983- University of Washington School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 1995 - 2026
FL State Medical License 2021 - 2025
CO State Medical License 1986 - 1999
NM State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease Start of enrollment: 2014 Jun 27
- A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Start of enrollment: 2020 Sep 29
Publications & Presentations
PubMed
- 55 citationsHealth status in the TORCH study of COPD: treatment efficacy and other determinants of changePaul W. Jones, Julie A. Anderson, Peter M.A. Calverley, Bartolome R. Celli, Gary T. Ferguson
Respiratory Research. 2011-05-31 - 350 citationsOffice spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.Gary T. Ferguson, Paul L. Enright, A. Sonia Buist, Millicent Higgins
Chest. 2000-04-01 - 567 citationsEffect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease Results from the TORCH StudyBartolome R. Celli, Nicola E. Thomas, Julie A. Anderson, Gary T. Ferguson, Christine Jenkins
American Journal of Respiratory and Critical Care Medicine. 2008-08-15
Press Mentions
Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023May 2nd, 2023- CHEST: ETHOS Sub-Analysis Confirms Triple Therapy BenefitOctober 23rd, 2020
